CoreAge Rx vs Heva Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Heva Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Heva Health a bad call — it's best for readers choosing between prepaid compounded care and a branded prescription who will confirm treatment-state access and the governing cancellation agreement. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Heva Health |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $522 paid upfront for three months Compounded package includes consultation, medication, supplies and two check-ins; separate six-month package advertised at $894. No automatic package renewal advertised; early-exit FAQ discusses possible fees/balance. Brand care $99/month excludes medication. Terms promise pre-fulfillment cancellation refunds including consultation/labs. Full price detailsCompounded semaglutide offered; complete selected-plan quote unknown; default three-month package $522 paid upfront, six-month package separately advertised at $894; $99/month branded care excludes medication |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $899 paid upfront for three months Compounded package with no automatic renewal advertised; not available in AK, AR, IN or SC. $99/month Zepbound care excludes medication. Cards and early-exit FAQ differ on commitment consequences. Terms promise full pre-fulfillment cancellation and clinical-unsuitability refunds; confirm the pharmacy processing stage. Full price detailsCompounded tirzepatide offered; complete selected-plan quote unknown; default three-month package $899 paid upfront, no automatic renewal advertised; $99/month Zepbound care excludes medication |
| Coverage | US only; restrictions by state, confirmed at intake | Direct-access network advertised nationwide, but tirzepatide page excludes AK, AR, IN and SC; full-service clinic care has a separate 12-state list |
| Brand-name access | Not confirmed | Named Wegovy, Zepbound and oral Foundayo programs are advertised; their $99/month charge covers care only, with medication purchased separately. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Heva Health: Compounded defaults:522 semaglutide/899 tirzepatide paid upfront for3months. Brandcare99/month excludesdrug. Tirz excludesAK/AR/IN/SC; package early-exit terms need confirmation.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.